#oncologia
oncologia
75 views
2 Discussing
Hot
Latest
💊 REVOLUTION MEDICINES LAUNCHES TREATMENT AGAINST PANCREATIC CANCER FOR $475,000 A YEAR 🧬
The U.S. FDA has approved Rasonque, a daily drug developed by Revolution Medicines to treat advanced pancreatic cancer, Bloomberg reported 🩺.
The medication, available starting Wednesday at an annual cost of over $475,000, stands out for extending patients’ survival 📊.
It works by inhibiting the RAS protein, a genetic mutation present in most of these tumors, positioning itself as one of the most expensive and innovative precision therapies in the biotechnology sector 🚀.
#RevolutionMedicines #Salud #WallStreet #Biotecnologia #Oncologia
$BTC
$ETH
$BNB
The U.S. FDA has approved Rasonque, a daily drug developed by Revolution Medicines to treat advanced pancreatic cancer, Bloomberg reported 🩺.
The medication, available starting Wednesday at an annual cost of over $475,000, stands out for extending patients’ survival 📊.
It works by inhibiting the RAS protein, a genetic mutation present in most of these tumors, positioning itself as one of the most expensive and innovative precision therapies in the biotechnology sector 🚀.
#RevolutionMedicines #Salud #WallStreet #Biotecnologia #Oncologia
$BTC
$ETH
$BNB
Log in to explore more content